Article
Bantu Tanzanians have a decreased capacity to metabolize omeprazole and mephenytoin in relation to their CYP2C19 genotype.
Clinical pharmacology and therapeutics - 1 Oct 1998
Herrlin K, Massele A Y, Jande M, Alm C, Tybring G, Abdi Y A, Wennerholm A, Johansson I, Dahl M L, Bertilsson L, Gustafsson L L
Abstract excerpt
OBJECTIVE: To investigate the CYP2C19 polymorphism in Tanzanians because this enzyme shows large interindividual differences in activity and metabolizes several drugs of importance in Africa, especially the antimalarial agent chloroguanide (INN, proguanil). METHODS: Two hundred fifty-one Tanzania...
Topics
- Administration, Oral
- Adolescent
- Adult
- Alleles
- Anti-Ulcer Agents
- Anticonvulsants
- Aryl Hydrocarbon Hydroxylases
- Black People
- Cytochrome P-450 CYP2C19
- Cytochrome P-450 Enzyme System
- DNA Primers
- Enzyme Inhibitors
- Female
- Genotype
- Humans
